comparemela.com

Latest Breaking News On - Northsea therapeutic - Page 1 : comparemela.com

The Rising NAFLD/NASH Epidemic Coupled with High Patient Need Offers Opportunities for Pharmaceutical Manufacturers to Capitalize Across Various Disease Stages, According to Spherix Global Insights

/PRNewswire/ The non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) epidemic is roughly 2.5 times greater than diabetes in the U.S..

Inventiva pharmaNovo nordiskSpherix networkMadrigal pharmaceuticalsGastrointestinal disease advisory committeeNew spherixIntercept pharmaceuticalObeticholic acidMarket dynamixAkero therapeuticsViking therapeuticsMadrigal pharmaceuticalNorthsea therapeuticGalmed pharmaceuticalGlobal insightsSpherix global insights

NorthSea Therapeutics Appoints Morris J Birnbaum to the Board

Former Pfizer Internal Medicine CSO joins the Board as an independent board member NorthSea Therapeutics B.V. ('NST'), a biotech company developing novel and innovative strategies for the treatment

New yorkUnited statesUnited kingdomSan franciscoPronova biopharma norgeKostenloser wertpapierhandelMorrisj birnbaumMorris birnbaumMedicine research unitUniversity of californiaHarvard medical schoolPfizer inc in cambridgePerelman school of medicineSloan kettering instituteBarnes hospital at washington university in stUniversity of pennsylvania

vimarsana © 2020. All Rights Reserved.